7-107298208-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006348.5(COG5):​c.1247A>G​(p.Tyr416Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0062 in 1,613,714 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0052 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0063 ( 39 hom. )

Consequence

COG5
NM_006348.5 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.583

Publications

7 publications found
Variant links:
Genes affected
COG5 (HGNC:14857): (component of oligomeric golgi complex 5) The protein encoded by this gene is one of eight proteins (Cog1-8) which form a Golgi-localized complex (COG) required for normal Golgi morphology and function. The encoded protein is organized with conserved oligomeric Golgi complex components 6, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants. Mutations in this gene result in congenital disorder of glycosylation type 2I.[provided by RefSeq, Jan 2011]
COG5 Gene-Disease associations (from GenCC):
  • COG5-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003083676).
BP6
Variant 7-107298208-T-C is Benign according to our data. Variant chr7-107298208-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194075.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00516 (786/152272) while in subpopulation NFE AF = 0.00798 (543/68014). AF 95% confidence interval is 0.00743. There are 4 homozygotes in GnomAd4. There are 367 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COG5NM_006348.5 linkc.1247A>G p.Tyr416Cys missense_variant Exon 12 of 22 ENST00000297135.9 NP_006339.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COG5ENST00000297135.9 linkc.1247A>G p.Tyr416Cys missense_variant Exon 12 of 22 1 NM_006348.5 ENSP00000297135.4
COG5ENST00000347053.8 linkc.1247A>G p.Tyr416Cys missense_variant Exon 12 of 21 1 ENSP00000334703.3
COG5ENST00000393603.7 linkc.1247A>G p.Tyr416Cys missense_variant Exon 12 of 21 1 ENSP00000377228.3

Frequencies

GnomAD3 genomes
AF:
0.00517
AC:
786
AN:
152154
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00798
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00474
AC:
1192
AN:
251284
AF XY:
0.00478
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00515
Gnomad ASJ exome
AF:
0.00506
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.00767
Gnomad OTH exome
AF:
0.00572
GnomAD4 exome
AF:
0.00631
AC:
9222
AN:
1461442
Hom.:
39
Cov.:
30
AF XY:
0.00620
AC XY:
4509
AN XY:
727048
show subpopulations
African (AFR)
AF:
0.00105
AC:
35
AN:
33468
American (AMR)
AF:
0.00521
AC:
233
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00455
AC:
119
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39634
South Asian (SAS)
AF:
0.000499
AC:
43
AN:
86246
European-Finnish (FIN)
AF:
0.00152
AC:
81
AN:
53398
Middle Eastern (MID)
AF:
0.00642
AC:
37
AN:
5762
European-Non Finnish (NFE)
AF:
0.00749
AC:
8331
AN:
1111716
Other (OTH)
AF:
0.00566
AC:
342
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
409
817
1226
1634
2043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00516
AC:
786
AN:
152272
Hom.:
4
Cov.:
32
AF XY:
0.00493
AC XY:
367
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41560
American (AMR)
AF:
0.00471
AC:
72
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10602
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00798
AC:
543
AN:
68014
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00651
Hom.:
12
Bravo
AF:
0.00506
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00458
AC:
556
Asia WGS
AF:
0.000289
AC:
1
AN:
3476
EpiCase
AF:
0.00884
EpiControl
AF:
0.0107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

COG5-congenital disorder of glycosylation Uncertain:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 05, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COG5: BP4, BS2 -

Apr 12, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.044
DANN
Benign
0.72
DEOGEN2
Benign
0.0066
T;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.68
T;T;T
MetaRNN
Benign
0.0031
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
-0.58
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.69
N;N;N
REVEL
Benign
0.046
Sift
Benign
0.14
T;T;T
Sift4G
Benign
0.18
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.21
MVP
0.34
MPC
0.065
ClinPred
0.00032
T
GERP RS
-4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.052
gMVP
0.38
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41276187; hg19: chr7-106938653; API